CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522007292
- Phone
- (858) 704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-27 | Williams Donald Allen Director | Purchase | +20,000 | $0.54 | $11K | 20,000 |
| 2023-09-27 | Finley John David CEO, CFO, Director | Purchase | +15,000 | $0.54 | $8K | 43,394 |
| 2023-09-14 | Trenschel Robert J. Director | Sale | −300 | $0.64 | $192 | 0 |
| 2023-09-13 | Finley John David CEO, CFO, Director | Purchase | +15,000 | $0.66 | $10K | 28,394 |
| 2023-09-12 | Finley John David CEO, CFO, Director | Shares withheld for taxes | −1,792 | $0.66 | $1K | 13,394 |
| 2023-09-11 | Finley John David CEO, CFO, Director | Option exercise | +5,558 | 15,186 | ||
| 2023-09-11 | Finley John David CEO, CFO, Director | Option exercise · Restricted Stock Units | −5,558 | 61,142 | ||
| 2023-08-11 | Finley John David CEO, CFO, Director | Shares withheld for taxes | −1,040 | $0.70 | $728 | 9,628 |
| 2023-08-06 | Finley John David CEO, CFO, Director | Option exercise | +3,475 | 11,057 | ||
| 2023-08-06 | Finley John David CEO, CFO, Director | Option exercise · Restricted Stock Units | −3,475 | 34,750 | ||
| 2023-07-06 | Finley John David CEO, CFO, Director | Shares withheld for taxes | −389 | $1.76 | $686 | 7,193 |
| 2023-07-03 | Finley John David CEO, CFO, Director | Option exercise | +1,309 | 7,582 | ||
| 2023-07-03 | Finley John David CEO, CFO, Director | Option exercise · Restricted Stock Units | −1,309 | 2,618 | ||
| 2023-06-13 | Finley John David CEO, CFO, Director | Shares withheld for taxes | −1,050 | $1.54 | $2K | 6,273 |
| 2023-06-12 | Finley John David CEO, CFO, Director | Option exercise | +3,475 | 7,323 | ||
| 2023-06-12 | Finley John David CEO, CFO, Director | Option exercise · Restricted Stock Units | −3,475 | 38,225 | ||
| 2023-06-11 | Trenschel Robert J. Director | Grant or award · Restricted Stock Units | +5,100 | 5,100 | ||
| 2023-06-11 | Trenschel Robert J. Director | Grant or award · Common Stock Options | +12,160 | 12,160 | ||
| 2023-06-11 | GRAY MARY ANN Director | Grant or award · Restricted Stock Units | +5,100 | 5,100 | ||
| 2023-06-11 | GRAY MARY ANN Director | Grant or award · Common Stock Options | +12,160 | 12,160 |
Page 10 of 12 · 233 trades